Zeo ScientifiX's revenue per share for the
three
months ended in Jan. 2024 was $0.00.
Zeo ScientifiX's revenue per share for the trailing twelve months (TTM) ended in Jan. 2024 was $0.48.
Warning Sign:
Zeo ScientifiX Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Zeo ScientifiX was -41.90% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 422.90% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 246.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Zeo ScientifiX's Revenue per Share or its related term are showing as below:
ZEOX'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.6 Med: 36.3 Max: 582.6
Current: 422.9
During the past 13 years, Zeo ScientifiX's highest 3-Year average Revenue Per Share Growth Rate was 582.60% per year. The lowest was -4.60% per year. And the median was 36.30% per year.
ZEOX's 3-Year Revenue Growth Rate is ranked better than 98.2% of 777
companies
in the Biotechnology industry
Industry Median: 3.5
vs ZEOX: 422.90
Zeo ScientifiX Revenue per Share Historical Data
The historical data trend for Zeo ScientifiX's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zeo ScientifiX's Revenue per Share
For the Biotechnology subindustry, Zeo ScientifiX's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's PS Ratio distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's PS Ratio falls into.
Zeo ScientifiX Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Zeo ScientifiX's Revenue Per Share for the fiscal year that ended in Oct. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.48
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX (OTCPK:ZEOX) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Zeo ScientifiX Revenue per Share Related Terms
Thank you for viewing the detailed overview of Zeo ScientifiX's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Zeo ScientifiX (Zeo ScientifiX) Business Description
Organicell Regenerative Medicine Inc is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. Its product candidate, Zofinis an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs, without the addition or combination of any other substance or diluent. Zofin is in Phase I/II clinical trials to treat Long COVID and COPD and Osteoarthritis. The company has entered an agreement with CDC to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZEOX has been successfully added to your 